Dr. Reddy's Laboratories Limited (DRREDDY) — Announcement Announcement
📢 Key Event
Dr. Reddy's to ring NYSE closing bell for 25th listing anniversary
💡 Investor Takeaway
This milestone underscores Dr. Reddy's enduring global market presence and commitment to shareholder value through sustained innovation.
Dr. Reddy's Laboratories announced it will ring the closing bell at the New York Stock Exchange on May 29, 2026, to commemorate 25 years since its historic 2001 listing as the first Asian pharmaceutical company outside Japan to list on NYSE. The ceremony will be livestreamed and attended by senior leadership including Chairman Satish Reddy, celebrating the company's legacy of affordable innovation and global impact.
📄 View Original Announcement (PDF)
About Dr. Reddy's Laboratories Limited (DRREDDY)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
Market Cap: ₹1,11,568.6 Cr
P/E: 20.0
ROE: 16.6%
ROCE: 19.7%
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.